Osmetech, Fisher Healthcare Terminate Distribution Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Osmetech today said that its US distribution agreement with Thermo Fisher's Fisher Healthcare, which was signed earlier this year, has been terminated.

According to the UK-based molecular diagnostics firm, the firms mutually agreed to terminate the five-year contract, which was signed at the end of March.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.